Molecular insight into the smart functionalized TMC-Fullerene nanocarrier in the pH-responsive adsorption and release of anti-cancer drugs

Copyright © 2020 Elsevier Inc. All rights reserved..

The Doxorubicin (DOX) and Paclitaxel (PAX) are widely used for cancer-therapy. Herein, in the efforts devoted to developing smart drug carriers, the loading and releasing of the DOX and PAX on the pH sensitive functionalized Fullerene carrier was investigated by molecular dynamics (MD) simulations. The effects of chitosan polymer as a functionalizing agent of the Fullerene carrier was also studied. In addition, the Fullerene carrier was functionalized with carboxyl groups in order to improve the loading and releasing properties of the DOX and PAX. The results showed the DOX is well adsorbed on Fullerene which was functionalized with carboxyl group and it was released controllably in cancerous tissues. According to the results of the electrostatic and Van der Waals interactions, it was found that the functionalized Fullerene can be a proper carrier for DOX in comparison with PAX. Adding the trimethyl chitosan (TMC) polymer to the carrier could improve the Van der Waals attractions of the PAX and Fullerene which indicates that by passing the time at acidic pH, the Van der Waals energy reaches zero that leads to promote the release of the PAX in cancerous tissues. The carboxyl group which was employed as a functionalizing agent could also increase the number of hydrogen bonds for the PAX and DOX at acidic and neutral pH, respectively. Moreover, a significant rise in the number of hydrogen bonds between the PAX and Fullerene at neutral pH was achieved by adding the TMC to the carrier. A more decrease of gyration radius was obtained for the DOX at acidic pH which confirms that the DOX with TMC-Fullerene is a more stable carrier. So, this smart nanomedicine system is introduced as an promising composition for smart cancer therapy.

Medienart:

E-Artikel

Erscheinungsjahr:

2020

Erschienen:

2020

Enthalten in:

Zur Gesamtaufnahme - volume:100

Enthalten in:

Journal of molecular graphics & modelling - 100(2020) vom: 16. Nov., Seite 107660

Sprache:

Englisch

Beteiligte Personen:

Maleki, Reza [VerfasserIn]
Khoshoei, Azadeh [VerfasserIn]
Ghasemy, Ebrahim [VerfasserIn]
Rashidi, Alimorad [VerfasserIn]

Links:

Volltext

Themen:

80168379AG
9012-76-4
Antineoplastic Agents
Cancer-therapy
Chitosan
Doxorubicin
Doxorubicin (DOX)
Drug Carriers
Fullerene
Fullerenes
Journal Article
Nanomedicine
Paclitaxel (PAX)

Anmerkungen:

Date Completed 21.06.2021

Date Revised 21.06.2021

published: Print-Electronic

Citation Status MEDLINE

doi:

10.1016/j.jmgm.2020.107660

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM312362684